Bortezomib
Links shared publicly online about this topic
Bortezomib Promising Treatment for Rheumatoid Arthritis
disabled-world.com — “Study suggests biologic drug bortezomib (Velcade) may represent a promising treatment for rheumatoid arthritis” View full resource at disabled-world.com
Most Recently Shared on November 4, 2010 at 1:39 pm By:
Disabled World Health Advocate and Health News
Bortezomib Promising Treatment for Rheumatoid Arthritis http://ff.im/-t9rfq
Pediatrics Medical News about bortezomib
mdlinx.com — “Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia (TACL) consortium” View full resource at mdlinx.com
Most Recently Shared on May 5, 2010 at 6:28 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblasti... http://bit.ly/bBmCH4 #peds
VELCADE (Bortezomib) drug information from MPR
empr.com — “VELCADE (Bortezomib) drug information for Lymphoma, mantle cell, Multiple myeloma, Neoplasms from MPR including side effects, drug interactions, dosing, contraindications and precautions.” View full resource at empr.com
Most Recently Shared on March 30, 2010 at 5:14 am By:
MPR News: VELCADE: Adults: added hepatic impairment dosing. http://bit.ly/d4qz5W
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myelom
thelancet.com — “Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and pre...” View full resource at thelancet.com
Most Recently Shared on August 24, 2010 at 9:05 am By:
A trial looks at optimising the dose of bortezomib for elderly patients with previously untreated multiple myeloma http://bit.ly/anPFjo
Study finds bortezomib to be promising treatment for rheumatoid arthritis
physorg.com — “A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model ...” View full resource at physorg.com
Most Recently Shared on November 3, 2010 at 4:26 pm By:
Study finds bortezomib to be promising treatment for rheumatoid arthritis http://bit.ly/dld92C
Internal Med Medical News about Bortezomib
mdlinx.com — “Phase I Trial of Fixed-Dose Rate Gemcitabine in Combination with Bortezomib in Advanced Solid Tumors” View full resource at mdlinx.com
Most Recently Shared on February 19, 2010 at 10:08 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Int Med: Phase I Trial of Fixed-Dose Rate Gemcitabine in Combination with Bortezomib in Advanced Solid Tumors: Anticanc http://url4.eu/1RCLv
FDA Alert: Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
drugs.com — “FDA Alert: Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment” View full resource at drugs.com
Most Recently Shared on January 27, 2010 at 12:59 am By:
FDA Alert - Velcade - Revisions to Prescribing Information - http://bit.ly/9zn2GT
NICE Draft Guidance Recommends Bortezomib And Thalidomide For Multiple Myeloma
medicalnewstoday.com — “In draft guidance published NICE has recommended two new treatments for multiple myeloma. Thalidomide (Thalidomide, Celgene) in combination with an alkylating agent and a corticosteroid i” View full resource at medicalnewstoday.com
Most Recently Shared on June 4, 2010 at 1:05 am By:
NICE Draft Guidance Recommends Bortezomib And Thalidomide For Multiple Myeloma http://mnt.to/3Dtv #cancer
IngentaConnect Bortezomib/thalidomide: Nonspecific interstitial pneumonia in an ...
ingentaconnect.com — “IngentaConnect Bortezomib/thalidomide: Nonspecific interstitial pneumonia in an ...” View full resource at ingentaconnect.com
Most Recently Shared on August 16, 2010 at 10:58 pm By:
Bortezomib/thalidomide: Nonspecific interstitial pneumonia in an elderly patient: case report: (Source: Reactions) http://bit.ly/9lTEcs
ingentaconnect Genetic factors play role in bortezomib-induced neuropathy
ingentaconnect.com — “ingentaconnect Genetic factors play role in bortezomib-induced neuropathy” View full resource at ingentaconnect.com
Most Recently Shared on November 15, 2010 at 8:07 am By:
Drugs and Devices OW OW Health
Genetic factors play role in bortezomib-induced neuropathy: (Source: Reactions) http://bit.ly/9H5CMK
Study makes exciting progress in elucidating the mechanisms of bortezomib in lymphoma
physorg.com — “A new study by researchers from the John Theurer Cancer Center at Hackensack University Medical Center sheds light on how bortezomib (VELCADE), the first in a new class of cancer drugs known as proteasome inhibitors, works in mantle cell lymphoma. The study also provides preliminary evidence for which ...” View full resource at physorg.com
Most Recently Shared on July 12, 2010 at 8:20 pm By:
PhysOrg Health News Health News
Study makes exciting progress in elucidating the mechanisms of bortezomib in lymphoma http://tw.physorg.com/198168362
Bortezomib Useful for Fibrosis or Too Early to Tell? - QualityPoint Technologies
qualitypointtech.net — “Studies in an animal and in cultured cells from a patient with scleroderma show that proteasome inhibitors may have a role in treating scleroderma and related conditions. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on October 10, 2011 at 8:00 pm By:
Bortezomib Useful for Fibrosis or Too Early to Tell?: Studies in an animal and in cultured cells from a patient wi... http://t.co/j6EIQLnX
EMEA Approves Update To Velcade(R) (Bortezomib) Label To Include Survival Benefit In Previously Untreated Patients With Multiple Myeloma
medicalnewstoday.com — “Janssen-Cilag welcomes the approval by the European Commission of the update to the Summary of Product Characteristics (SmPC) for Velcade® (bortezomib) for the treatment of patients with multi” View full resource at medicalnewstoday.com
Most Recently Shared on June 17, 2010 at 4:05 pm By:
EMEA Approves Update To Velcade(R) (Bortezomib) Label To Include Survival Benefit In Previously Untreated Patients Wit... http://mnt.to/3F22
NICE guidance on bortezomib and thalidomide for first-line treatment of multiple myeloma : The Lancet Oncology
thelancet.com — “NICE guidance on bortezomib and thalidomide for first-line treatment of multiple myeloma. By - Sally Doss, Nicola Hay, Frances Sutcliffe” View full resource at thelancet.com
Most Recently Shared on July 27, 2011 at 9:12 am By:
NICE guidance on bortezomib and thalidomide for first-line treatment of multiple myeloma http://t.co/EEmyv3i #Oncology @NICEcomms
Bortezomib-induced peripheral neuropathy: facts and genes -- Authors' reply : The Lancet Oncology
thelancet.com — “Bortezomib-induced peripheral neuropathy: facts and genes -- Authors' reply. By - Annemiek Broyl, Joost LM Jongen, Pieter Sonneveld” View full resource at thelancet.com
Most Recently Shared on January 30, 2011 at 3:23 pm By:
[Correspondence] Bortezomib-induced peripheral neuropathy: facts and genes – Authors' reply: Cavaletti states ... http://bit.ly/h2vcsE
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Disabled World
Disabled World is managed by Lynn and Ian Langtree, a couple dedicated to assisting seniors and people with disabilities.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
